Zobrazeno 1 - 10
of 522
pro vyhledávání: '"Kudwa AE"'
Autor:
Hoare SRJ; Pharmechanics LLC, Owego, New York (S.R.J.H.); Neurocrine Biosciences, Inc., San Diego, California (A.E.K., D.E.G.); and Crinetics Pharmaceuticals Inc., San Diego, California (R.L.)., Kudwa AE; Pharmechanics LLC, Owego, New York (S.R.J.H.); Neurocrine Biosciences, Inc., San Diego, California (A.E.K., D.E.G.); and Crinetics Pharmaceuticals Inc., San Diego, California (R.L.)., Luo R; Pharmechanics LLC, Owego, New York (S.R.J.H.); Neurocrine Biosciences, Inc., San Diego, California (A.E.K., D.E.G.); and Crinetics Pharmaceuticals Inc., San Diego, California (R.L.)., Grigoriadis DE; Pharmechanics LLC, Owego, New York (S.R.J.H.); Neurocrine Biosciences, Inc., San Diego, California (A.E.K., D.E.G.); and Crinetics Pharmaceuticals Inc., San Diego, California (R.L.) dgrigoriadis@neurocrine.com.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2022 May; Vol. 381 (2), pp. 79-95. Date of Electronic Publication: 2022 Feb 23.
Autor:
Reis, Leriana Garcia1 (AUTHOR), Teeple, Kelsey1 (AUTHOR), Schoonmaker, Jenna Lynn1 (AUTHOR), Davis, Corrin1 (AUTHOR), Scinto, Sara1 (AUTHOR), Schinckel, Allan1 (AUTHOR), Casey, Theresa1 (AUTHOR) theresa-casey@purdue.edu
Publikováno v:
PLoS ONE. 11/20/2024, Vol. 19 Issue 11, p1-19. 19p.
Autor:
Vasilkovska, Tamara1,2 (AUTHOR) tamara.vasilkovska@ucsf.edu, Verschuuren, Marlies2,3,4 (AUTHOR), Pustina, Dorian5 (AUTHOR), van den Berg, Monica1,2 (AUTHOR), Van Audekerke, Johan1,2 (AUTHOR), Pintelon, Isabel2,3,4 (AUTHOR), Cachope, Roger5 (AUTHOR), De Vos, Winnok H.2,3,4 (AUTHOR), Van der Linden, Annemie1,2 (AUTHOR), Adhikari, Mohit H.1,2 (AUTHOR) mohit.adhikari@uantwerpen.be, Verhoye, Marleen1,2 (AUTHOR)
Publikováno v:
Clinical & Translational Medicine. Oct2024, Vol. 14 Issue 10, p1-24. 24p.
Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease.
Autor:
Zeitler B; Sangamo Therapeutics, Inc., Richmond, CA, USA. bzeitler@sangamo.com., Froelich S; Sangamo Therapeutics, Inc., Richmond, CA, USA., Marlen K; Sangamo Therapeutics, Inc., Richmond, CA, USA., Shivak DA; Sangamo Therapeutics, Inc., Richmond, CA, USA., Yu Q; Sangamo Therapeutics, Inc., Richmond, CA, USA., Li D; Sangamo Therapeutics, Inc., Richmond, CA, USA., Pearl JR; Sangamo Therapeutics, Inc., Richmond, CA, USA., Miller JC; Sangamo Therapeutics, Inc., Richmond, CA, USA., Zhang L; Sangamo Therapeutics, Inc., Richmond, CA, USA., Paschon DE; Sangamo Therapeutics, Inc., Richmond, CA, USA., Hinkley SJ; Sangamo Therapeutics, Inc., Richmond, CA, USA., Ankoudinova I; Sangamo Therapeutics, Inc., Richmond, CA, USA., Lam S; Sangamo Therapeutics, Inc., Richmond, CA, USA., Guschin D; Sangamo Therapeutics, Inc., Richmond, CA, USA.; Laboratory of Intracellular Signalling, Moscow Institute of Physics and Technology, Dolgoprudnyi, Russian Federation., Kopan L; Sangamo Therapeutics, Inc., Richmond, CA, USA., Cherone JM; Sangamo Therapeutics, Inc., Richmond, CA, USA., Nguyen HB; Sangamo Therapeutics, Inc., Richmond, CA, USA., Qiao G; Sangamo Therapeutics, Inc., Richmond, CA, USA., Ataei Y; Sangamo Therapeutics, Inc., Richmond, CA, USA., Mendel MC; Sangamo Therapeutics, Inc., Richmond, CA, USA., Amora R; Sangamo Therapeutics, Inc., Richmond, CA, USA., Surosky R; Sangamo Therapeutics, Inc., Richmond, CA, USA., Laganiere J; Sangamo Therapeutics, Inc., Richmond, CA, USA.; Medical Affairs and Innovation, Hema-Quebec, Quebec City, Quebec, Canada., Vu BJ; Sangamo Therapeutics, Inc., Richmond, CA, USA., Narayanan A; Sangamo Therapeutics, Inc., Richmond, CA, USA., Sedaghat Y; Evotec AG, Hamburg, Germany., Tillack K; Evotec AG, Hamburg, Germany., Thiede C; Evotec AG, Hamburg, Germany., Gärtner A; Evotec AG, Hamburg, Germany., Kwak S; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Bard J; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Mrzljak L; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Park L; CHDI Management/CHDI Foundation, Los Angeles, CA, USA., Heikkinen T; Charles River Discovery Services, Kuopio, Finland., Lehtimäki KK; Charles River Discovery Services, Kuopio, Finland., Svedberg MM; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm, Sweden., Häggkvist J; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm, Sweden., Tari L; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm, Sweden., Tóth M; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm, Sweden., Varrone A; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm, Sweden., Halldin C; Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, Stockholm, Sweden., Kudwa AE; Psychogenics, Inc., Paramus, NJ, USA., Ramboz S; Psychogenics, Inc., Paramus, NJ, USA., Day M; Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Kondapalli J; Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Surmeier DJ; Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Urnov FD; Sangamo Therapeutics, Inc., Richmond, CA, USA.; Innovative Genomics Institute, Berkeley, CA, USA., Gregory PD; Sangamo Therapeutics, Inc., Richmond, CA, USA., Rebar EJ; Sangamo Therapeutics, Inc., Richmond, CA, USA., Muñoz-Sanjuán I; CHDI Management/CHDI Foundation, Los Angeles, CA, USA. ignacio.munoz@chdifoundation.org., Zhang HS; Sangamo Therapeutics, Inc., Richmond, CA, USA.; Applied StemCell, Inc., Milpitas, CA, USA.
Publikováno v:
Nature medicine [Nat Med] 2019 Jul; Vol. 25 (7), pp. 1131-1142. Date of Electronic Publication: 2019 Jul 01.
Autor:
Martin-Solana, Eva1 (AUTHOR), Casado-Zueras, Laura2 (AUTHOR), Torres, Teobaldo E.2,3,4,5 (AUTHOR), Goya, Gerardo F.3,4 (AUTHOR), Fernandez-Fernandez, Maria-Rosario6 (AUTHOR) MR.Fernandez@csic.es, Fernandez, Jose-Jesus6 (AUTHOR) JJ.Fernandez@csic.es
Publikováno v:
Acta Neuropathologica Communications. 6/5/2024, Vol. 12 Issue 1, p1-14. 14p.
Autor:
Koch, Ellen T.1,2 (AUTHOR) ellen.koch@ucalgary.ca, Cheng, Judy1,3 (AUTHOR), Ramandi, Daniel1,4 (AUTHOR), Sepers, Marja D.1 (AUTHOR), Hsu, Alex5 (AUTHOR), Fong, Tony1,3 (AUTHOR), Murphy, Timothy H.1 (AUTHOR), Yttri, Eric5 (AUTHOR), Raymond, Lynn A.1 (AUTHOR)
Publikováno v:
BMC Biology. 5/23/2024, Vol. 22 Issue 1, p1-19. 19p.
Autor:
Vasilkovska, Tamara1,2 (AUTHOR) tamara.vasilkovska@uantwerpen.be, Salajeghe, Somaie1 (AUTHOR), Vanreusel, Verdi1 (AUTHOR), Van Audekerke, Johan1,2 (AUTHOR), Verschuuren, Marlies2,3,4 (AUTHOR), Hirschler, Lydiane5 (AUTHOR), Warnking, Jan6 (AUTHOR), Pintelon, Isabel2,3,4 (AUTHOR), Pustina, Dorian7 (AUTHOR), Cachope, Roger7 (AUTHOR), Mrzljak, Ladislav7,8 (AUTHOR), Muñoz-Sanjuan, Ignacio7,9 (AUTHOR), Barbier, Emmanuel L.6 (AUTHOR), De Vos, Winnok H.2,3,4 (AUTHOR), Van der Linden, Annemie1,2 (AUTHOR), Verhoye, Marleen1,2 (AUTHOR)
Publikováno v:
Journal of Biomedical Science. 4/17/2024, Vol. 31 Issue 1, p1-16. 16p.
Autor:
Atri Roozbahani, Golnaz1 (AUTHOR), Kokal-Ribaudo, Miriam1 (AUTHOR), Heidari Horestani, Mehdi1 (AUTHOR), Pungsrinont, Thanakorn1 (AUTHOR), Baniahmad, Aria1 (AUTHOR) aria.baniahmad@med.uni-jena.de
Publikováno v:
Cell Communication & Signaling. 4/8/2024, Vol. 22 Issue 1, p1-17. 17p.
Autor:
Sari, Mesut1 mesuthsari@gmail.com, Savcı, Uğur2, Balta, Büşra3, Öztürk, Yusuf4, Tufan, Ali Evren4
Publikováno v:
Current Approaches in Psychiatry / Psikiyatride Guncel Yaklasimlar. 2024, Vol. 16 Issue 1, p175-184. 10p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.